A study to compare the efficacy of gabapentin plus amitryptiline with amitryptiline alone for management of chemotherapy induced peripheral neuropathy.
Phase 4
- Conditions
- Health Condition 1: G620- Drug-induced polyneuropathy
- Registration Number
- CTRI/2017/07/009109
- Lead Sponsor
- ESI Institute of Pain Management ESI Hospital Sealdah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with cancer having neuropathic pain.
2. Patient on WHO ladder therapy for control of cancer related pain.
Exclusion Criteria
1. Patients with unstable cardiovascular, respiratory, hepatic or hematological disease or psychological disorder.
2. Patient having diabetes, HIV, Guillain-Barré syndrome, CIDP, radiculopathy.
3. Alchoholic,drug abuse patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method